HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Clinical trial NCT06844669 · TERMINATED

Trial details

NCT number: NCT06844669
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer HER2+ Breast Cancer

Start date: 2025-04-16
Primary completion: 2026-02-16
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.